News

News

Oxea Declares FM for Intermediates at Bay City

Oxea has declared force majeure for n/i butanol n/i butyl acetate-propanol and n-propyl acetate produced at its Bay City, Texas site.

News

ExxonMobil to Invest Over $1 Billion in Antwerp Refinery

News

Mitsubishi and Sabic Name Start-Up Date for Saudi MMA

News

Scotland May Have Shale to Meet 30 Years of UK Gas Needs

News

Bayer to Keep Acquired Non-drug Merck Brands

News

Merck Acquires Dutch Liquid Crystal Windows Specialist

News

Chevron Phillips to Expand Texas Alpha Olefins Unit

News

LG Chem Signs MOU to Build China EV Battery Plant

News

Roche to Buy US Biotech Firm Seragon for up to $1.7 Billion

News

Sex Video is New Twist in GSK China Bribery Scandal

News

Bayer CropScience in $29.6 Million Global Seeds HQ Expansion

News

Lanxess Starts New 90,000 t/y PA Plant in Belgium

4997 more News

Top-Feature

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Innovation Pitch

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

News

Top-Feature

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Upcoming Virtual Events

Innovation Pitch

Newsletter & e-edition